Mobile Home

Text Size:

Loading slider…
Click and drag to navigate

  • Animated Captions
    With Custom Effects For Each Item
    Button Example
  • Drag Navigation
    With Mobile Support
  • Autoplay Slideshow
    with Pause on Hover
  • Easy to Customize
    30+ Documented Options

Mobile Home

Loading slider…
Click and drag to navigate

  • Animated Captions
    With Custom Effects For Each Item
    Button Example
  • Drag Navigation
    With Mobile Support
  • Autoplay Slideshow
    with Pause on Hover
  • Easy to Customize
    30+ Documented Options
Posted on August 15, 2011 by alz01

Recent News

British Prime Minister David Cameron Visits Rockefeller University to Discuss Advances in Dementia Research

May 17, 2013

On Wednesday, May 15, 2013, British Prime Minister David Cameron visited The Rockefeller University where he met with President Marc Tessier-Lavigne, Nobel laureate Paul Greengard, and other scientists working on Alzheimer’s disease and related neurodegenerative conditions. The Prime Minister was … Continue reading →

A Range of Diagnostic Tests for Alzheimer’s

May 15, 2013

Various tests for diagnosing Alzheimer’s disease have become available in recent years, although they remain imperfect diagnostic tools. Now researchers at Duke University report that using a combination of tests – two types of brain scans along with analysis of … Continue reading →

Finding Dementia Sufferers Who Get Lost While Driving

May 15, 2013

Various methods may help boost success in finding drivers with Alzheimer’s disease or other forms of dementia who get lost, a new study suggests. They include prompt notification of law enforcement officers, detailed descriptions of the missing person and not … Continue reading →

Secondhand Smoke Increases Dementia Risk

May 15, 2013

Smoking has been linked to a host of ills, including an increased risk for Alzheimer’s disease and other forms of dementia. Now an international study has found that you don’t even have to be a smoker to suffer the deleterious … Continue reading →

Experimental Drug Solanezumab Shows Hints of Promise

April 29, 2013

An experimental drug showed promise of slowing cognitive decline in people in the early stages of Alzheimer’s, though the benefits were modest and the drug did not meet its main testing goals in a study of patients with mild to … Continue reading →

Toll Free: 1-800-ALZ-INFO or 1-800-259-4636      Email: info@alzinfo.org

This project was supported, in part, by a grant, number 90AZ2791, from the Administration on Aging, Department of Health and Human Services, Washington, D.C. 20201. Grantees undertaking projects under government sponsorship are encouraged to express freely their findings and conclusions. Points of view or opinions do not, therefore, necessarily represent official Administration on Aging policy.